Frederick Isasi serves as The Advisory Board Company’s Vice President of Health Policy and leads the firm’s newly formed Health Policy and Government Strategies division. He brings more than 15 years of experience working in health policy to the Advisory Board, joining the firm after serving five years as a Senior Legislative Counsel for Healthcare to U.S. Senator Jeff Bingaman, working on both the Finance Committee and Health Education Labor and Pension (HELP) Committee.
During his time in the Senate, Frederick helped shape numerous health care laws related to Medicare, Medicaid, the State Children's Health Insurance Program (SCHIP), Health Information Technology, oral healthcare, public health, and the Food and Drug Administration. In particular, he was a senior negotiator on the Affordable Care Act for the HELP Committee and in the Finance Committee "Gang of Six" discussions.
Before working in the Senate, Frederick was in private practice as a health policy attorney in Washington, D.C., where he advised hospitals and health systems across the country as well as state governors and Medicaid programs. He has also worked as a policy advisor to community health centers and as a biomedical researcher.
Frederick graduated with a JD from Duke University Law School in 2003, where he was staff editor for the Duke Journal of Gender Law and Policy. He received his Masters in Public Health from the University of North Carolina at Chapel Hill in 1999, where he was inducted into the Delta Omega national public health honor society. He received his Bachelors of Science from the University of Wisconsin-Madison in 1994 in cellular biology and Spanish.
Join us for an interactive webconference covering the federal government's continuing efforts to control health care spending and rein in the budget deficit, and what that means for our industry.
Explore the strategic, financial, and operational implications for hospitals and health systems—and discuss the ongoing political debate about the future of health care reform and provider reimbursement that will continue well beyond the election.
This presentation explores the implications of the presidential election for hospital and health system finances.